Search
Differentiation therapy holds promise as a targeted therapy for pediatric neuroblastoma
- OPACC
- Apr 1, 2014
- 1 min read
The important role of microRNAs in regulating neuroblastoma development has been unveiled by new research. This finding points to new therapeutic possibilities for one of the most common and lethal types of childhood cancers.
Recent Posts
See AllDuring cancer treatment, children can face hurdles to maintaining healthy eating. Chemotherapy has many side effects, including loss of...
Quality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
Comments